If you want more proof we waste medical school years teaching low value topics (krebs cycle) while failing to teach high value topics (evidence appraisal) then just note how many docs self prescribed hydroxychlorquine and horded it.

Our letter (& color fig!) HCQ in COVID @AnnalsofIM Great experience writing with @rheum_covid folks, including @rheum_cat @alhkim @jeffsparks @Larhumato @AliDuarteMD @SituationRheum @pekor002 @SattuiSEMD @emilysirotich @mugartegil @drkatiewebb @Drbeckyg https://t.co/KzeMXAT6rd https://t.co/dFVW7LyXfR

• Potential Public Health Harms of Rushing to Judgment | Annals of Internal Medi…

Should Rheum & Derm pts stop biological during #Covid_19? Likely not as a flare may put pts at risk of seeking medical attention or adding steroids. The #outbreak won’t be over for awhile. Ontario Rheum Assoc says take meds unless fever/SOB. J Article review @RheumNow @RheumInfo https://t.co/KDFAq482jt

This brief correspondence discusses the risks of uncontrolled RA and lupus resulting in increased risk of infection. (via @emilysirotich) Argues for continuing current treatments for our pts w/ inflammatory conditions (for now) https://t.co/o32cxeLsBL https://t.co/CoNeM8G6fq

• COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medicat…

HCQ in non-severe hospitalized COVID19, new single center RCT of 62pts Sx resolved ~1d sooner, a few more cleared CT findings Not peer rvwd, underpowered, unclear blinding/allocation, soft/non-validated outcomes, poorly reported Need. GOOD. RCTs. PDF: https://t.co/Mbrq7bFHk0 https://t.co/LcD2wbgyZm

• Articles I Have Tweeted About - Organized by Date - Google Drive

Listen to Dr. Alvin Wells "TED" like talk from RheumNow Live on 3/14/20 on why rheumatologists should be doing TeleRheumatology! Listen on iTunes or here>> https://t.co/279mKHnO3A

• https://bit.ly/2WVxcOk

Inzomelid, a selective, orall small molecule inhibitor of the NLRP3 inflammasome, has been tested in a phase I trial of CAPS (Cryopyrin-Associated Periodic Syndrome) https://t.co/8gO63xO9bC

• Inzomelid completes Phase I studies and shows positive results in the treatment…

Which DMARD goes best w/ a biologic? Metanalysis of 41 studies shows w/ TNFi, MTX is superior to other DMARDs; with RTX adding LEF is superior to MTX and with ABA the addition of MTX and non-MTX csDMARDs were equally effective. https://t.co/ukBNxR9c1u

• https://bit.ly/3dAkuKK

Corona infections are trending down in China, with no new cases reported in Hubei province, for the sixth consecutive day on Sunday. https://t.co/aY0SHzxyoJ

• China takes steps to heal virus-hit economy as infections fall - Reuters

The FDA has approved the investigational use of COVID-19 Convalescent Plasma - allowing clinicians to use as single-patient emergency Investigational New Drug Applications (INDs) - Must apply w/ form 3926 https://t.co/2oYWEYiB4f

• Investigational COVID-19 Convalescent Plasma - Emergency INDs | FDA

Weekly RheumNow Podcast is up! NEW WORLD ORDER; watch it here>> https://t.co/2VDHWoFq28 or listen to the podcast on iTunes or SoundCloud >> https://t.co/ElB9S9nlzY

• RheumNow Podcast – New World Order (3.27.20) | RheumNow - Rheumatology News & I…
• RheumNow Podcast – New World Order (3.27.20) | RheumNow - Rheumatology News & I…